This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Panchenko, E. Articles by Panchenko, E. Search for Related Content PubMed PubMed Citation Articles by Panchenko, E. Articles by Panchenko, E. Social Bookmarking                         What's this?

Effects of Indobufen and Pentoxifylline on Walking Capacity and Hemostasis in Patients with Intermittent Claudication: Results of Six Months of Treatment

A. Eshkeeva, MD

A. Dobrovolsky, PhD

E. Titaeva, MS

Ya. Podinovskaya, MS

K.M.A. Hussain, MD

Yu. Karpov, MD, DSc

Elizaveta Panchenko, MD

Department of Angiology Cardiology Research Center 3-rd Cherepkovskaya Street, 15A Moscow, 121552, Russia

Seventy-one patients with peripheral arterial occlusive disease (PAOD) were random ized into two groups of different treatment modalities. The diagnosis of PAOD was estab lished by history of intermittent claudication, clinical examination, and by Doppler pressure assessment or lower extremity arteriography. After a three-month washout period, 35 patients (Group 1) started treatment with indobufen (400 mg per day) and 36 patients (Group 2) with pentoxifylline (600 mg per day). Twenty-nine patients from each group completed six months of treatment. Both of the drugs significantly improved maximal and pain-free walking distances, but the effect of indobufen was more pronounced than that of pentoxifylline. Patients with PAOD exhibited signs of hyperco agulation. Fibrinogen, D-dimer, and b-thromboglobulin concentrations did not change significantly following treatment in both of the groups. The authors observed a decrease of platelet aggregation after treatment with indobufen and a decrease of F1+2 fragment and PAI-1 antigen after treatment with pentoxifylline.

Angiology, Vol. 48, No. 3, 247-254 (1997)
DOI: 10.1177/000331979704800308


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?